Rupenthal ID - Search Results

1

Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy.

Kuo CY, Maran JJ, Jamieson EG, Rupenthal ID, Murphy R, Mugisho OO. Kuo CY, et al. Among authors: rupenthal id. Int J Mol Sci. 2022 Nov 21;23(22):14471. doi: 10.3390/ijms232214471. Int J Mol Sci. 2022. PMID: 36430950 Free PMC article.

2

Role of gap junctions in chronic pain.

Wu A, Green CR, Rupenthal ID, Moalem-Taylor G. Wu A, et al. Among authors: rupenthal id. J Neurosci Res. 2012 Feb;90(2):337-45. doi: 10.1002/jnr.22764. Epub 2011 Oct 4. J Neurosci Res. 2012. PMID: 21971745 Review.

3

Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery.

Jacobs S, Bunt CR, Wu Z, Lehr CM, Rupenthal ID. Jacobs S, et al. Among authors: rupenthal id. Drug Dev Ind Pharm. 2012 Nov;38(11):1337-43. doi: 10.3109/03639045.2011.650646. Epub 2012 Feb 3. Drug Dev Ind Pharm. 2012. PMID: 22300392

4

The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release.

Mugisho OO, Green CR, Kho DT, Zhang J, Graham ES, Acosta ML, Rupenthal ID. Mugisho OO, et al. Among authors: rupenthal id. Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):385-393. doi: 10.1016/j.bbagen.2017.11.015. Epub 2017 Nov 21. Biochim Biophys Acta Gen Subj. 2018. PMID: 29158134

5

Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas.

Mugisho OO, Green CR, Zhang J, Binz N, Acosta ML, Rakoczy E, Rupenthal ID. Mugisho OO, et al. Among authors: rupenthal id. Int J Mol Sci. 2017 Nov 29;18(12):2567. doi: 10.3390/ijms18122567. Int J Mol Sci. 2017. PMID: 29186067 Free PMC article.

6

Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy.

Mugisho OO, Rupenthal ID, Squirrell DM, Bould SJ, Danesh-Meyer HV, Zhang J, Green CR, Acosta ML. Mugisho OO, et al. Among authors: rupenthal id. PLoS One. 2018 Aug 22;13(8):e0202156. doi: 10.1371/journal.pone.0202156. eCollection 2018. PLoS One. 2018. PMID: 30133488 Free PMC article.

7

Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease.

Mugisho OO, Green CR, Squirrell DM, Bould S, Danesh-Meyer HV, Zhang J, Acosta ML, Rupenthal ID. Mugisho OO, et al. Among authors: rupenthal id. J Mol Med (Berl). 2019 Feb;97(2):215-229. doi: 10.1007/s00109-018-1727-5. Epub 2018 Dec 8. J Mol Med (Berl). 2019. PMID: 30535867

8

Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy.

Mugisho OO, Green CR, Zhang J, Acosta ML, Rupenthal ID. Mugisho OO, et al. Among authors: rupenthal id. Drug Discov Today. 2019 Aug;24(8):1627-1636. doi: 10.1016/j.drudis.2019.01.011. Epub 2019 Jan 25. Drug Discov Today. 2019. PMID: 30690195 Review.

9

Depot formulations to sustain periocular drug delivery to the posterior eye segment.

Agban Y, Thakur SS, Mugisho OO, Rupenthal ID. Agban Y, et al. Among authors: rupenthal id. Drug Discov Today. 2019 Aug;24(8):1458-1469. doi: 10.1016/j.drudis.2019.03.023. Epub 2019 Mar 28. Drug Discov Today. 2019. PMID: 30930148 Review.

10

Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown.

Kuo C, Green CR, Rupenthal ID, Mugisho OO. Kuo C, et al. Among authors: rupenthal id. Acta Diabetol. 2020 Jan;57(1):13-22. doi: 10.1007/s00592-019-01352-3. Epub 2019 Apr 27. Acta Diabetol. 2020. PMID: 31030263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters